A major study presented today at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) face a 2.7-fold higher risk of death ...

Doha, Qatar: The Ministry of Public Health (MoPH) has advised the public, especially the vulnerable to take the Respiratory Syncytial Virus (RSV) vaccine as a proactive measure to protect against ...

is recommending that adults aged 50 to 59 years who are at increased risk for severe respiratory syncytial virus (RSV) disease receive a single dose of an RSV vaccine. The updated recommendation ...

Respiratory syncytial virus was linked to elevated incidence of cardiovascular events in older adults. Future research will help decide whether vaccination could reduce the impact of RSV on the heart.

FILE - This electron microscope image provided by the National Institutes of Health shows human respiratory syncytial virus (RSV) virions, colorized blue, and anti-RSV F protein/gold antibodies ...

An Australian-first study demonstrating the effectiveness of a new immunization against respiratory syncytial virus (RSV) for babies found it to be almost 90% effective in reducing hospitalization ...

About AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) AREXVY contains recombinant RSV glycoprotein F stabilized in the prefusion conformation (RSVPreF3). This antigen is combined with GSK ...

Australia is reporting high numbers of influenza, respiratory syncytial virus (RSV), and pertussis infections well ahead of winter, with concerns that declining vaccination rates could contribute ...

Adults with respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) have a 2.7-fold increased risk of death within a year compared to the general population.

Last year people aged between 75 and 79 and pregnant women were offered a first-of-its-kind jab against respiratory syncytial virus (RSV). The bug is responsible for some 50,000 hospitalisations ...

ATLANTA (AP) — A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as another option to protect teens against meningitis.